Healthcare Sales & Marketing Network News: Glucocorticoid-Induced

Searching News Database: Glucocorticoid-Induced

HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 10 May 2013
Novartis drug Ilaris(R) approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Biopharmaceuticals. FDA

HSMN NewsFeed - 11 Mar 2011
Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 6 Feb 2008
Barr Launches Generic Fosamax(R) Tablets, 70 mg
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 14 Nov 2007
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 8 Oct 2007
Teva Announces Approval of Generic Actonel(R)
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 2 Nov 2006
Osteologix Granted European Patent for Treating Cartilage and Bone Conditions
Biopharmaceuticals

Return to NewsFeed

Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 7 additional stories matching:
Glucocorticoid-Induced
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.